J&J Faces Trial in Risperdal Gynecomastia Claims
J&J Faces Trial in Risperdal Gynecomastia Claims Johnson & Johnson's Janssen Pharmaceuticals will defend itself against claims that Risperdal caused the boy to grow breasts that later had to be removed surgically — and will take on a former high-ranking FDA administrator in the process. Plaintiff's … Read more on …